Cardiology

Cardiac myosin inhibitors (CMI) are the first medications specifically targeting the underlying pathophysiology of hypertrophic cardiomyopathy

Heart Failure and Heart Failure with Preserved Ejection Fraction prognosis in relation to treatment with SGLT2 inhibitors…

JAK2-mediated thrombosis overlapping with silent myocardial infarction and an elevated eosinophil count associated with neuropathy…

Patients with COVID 19 with associated myocardial infarction and myocarditis, requiring myocarditis treatment…

Hidradenitis Suppurativa (HS) is a chronic inflammatory disease believed to be a risk factor for cardiovascular events…

A 71-year-old male with atrial fibrillation (AF) was admitted to the authors’ emergency department with fever, progressive dyspnoea…

Myocardial perfusion can be performed using several different methods. In clinical practice, robust techniques include single photon…

REDWOOD-HCM was a multicentre, randomised, placebo-controlled, double-blind, dose-finding clinical trial of aficamten in patients with symptomatic oHCM on background medical therapy.